Transaction · 0000950170-25-011327

Catinazzo Thomas

Catinazzo Thomas, CFO, reported an open-market or private sale at Relay Therapeutics, Inc. involving 20791.000000 shares for an estimated $91896.22. Reported holdings after the transaction were 379431.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCFO
RLAYRelay Therapeutics, Inc.
Filing timeJan 31
Trade dateJan 30, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

RLAY price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RLAY since 2025-01-31Filed 581 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000950170-25-011327
Common Stock
Transaction date
Jan 30, 2025
Filed Jan 31, 2025, 02:10 AM · 1d delay
Shares
20.7k sh
$442 per share
Estimated value
-$9.18M
Computed from shares × price
Holdings after
379k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Large Sale Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 105,723 shares of restricted stock units ("RSUs") on January 27, 2025. The reporting person had no…

  2. F2

    Includes 185,775 shares underlying RSUs.

  3. F3

    The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024.

  4. F4

    Represents RSUs granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock…

  5. vesting.

  6. F5

    Includes 324,916 shares underlying RSUs.

  7. F6

    Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 69,570 shares of RSUs on January 29, 2025. The reporting person had no discretion with respect to…

  8. F7

    Includes 255,346 shares underlying RSUs.

Original filing · 0000950170-25-011327
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RLAY